课题基金 / 基金详情

项目摘要

项目成果

Kim Janda的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请方提供):铜绿假单胞菌是一种常见的环境微生物,能够利用宿主免疫系统的弱点成为人类的机会致病菌。最突出的是铜绿假单胞菌在患有囊性纤维化的患者中的作用,因为肺防御功能严重受损。在过去的10年里,铜绿假单胞菌致病的分子机制研究取得了重大进展,其中群体感应起着重要作用。两种不同的AHL,由LasI合成的N-(3-氧代十二烷酰基)高丝氨酸内酯(3-oxo-C12-HSL)和由RhII合成的N-丁酰高丝氨酸内酯(C4-HSL),已被鉴定为铜绿假单胞菌中的主要群体感应信号分子。最近,我们发现了一种由3-氧代-C12-HSL非酶促形成的新产物,即新的特特拉姆酸产物,3-(1-羟基癸亚基)-5-(2-羟乙基)吡咯烷-2,4-二酮(C12-TA),这引起了微生物界的兴趣,正如我们的PNAS出版物收到的引用数量增加所证明的那样。可以想象,这种特特拉姆酸具有多种生物功能:铜绿假单胞菌可能使用C12-TA作为干扰策略,以阻止竞争细菌的侵入。此外,由于铁(III)与C12-TA的紧密和高度特异性结合,与已知的细菌铁载体相当,我们假设这种相互作用可能是以前未被认识到的铁溶解的原始机制,并可能为铜绿假单胞菌在复杂的细菌群落中提供竞争优势。或者,它可以作为铁螯合剂,从环境中去除游离铁,从而防止竞争细菌获得必需的铁,同时还可以作为铜绿假单胞菌的反馈环,以表达由铁饥饿Fur/PvdS转录调节因子控制的基因。值得注意的是,我们已经表明,C12-TA影响白色念珠菌的形态。总之,我们将提出一组假设,并通过高度集中的实验阐明N-(3-氧代十二烷酰基)高丝氨酸内酯衍生的C12-TA的分子特征和生化功能。公共卫生相关性:我们最近发现的一个新的nonenzymatally-formed产品来自主要的铜绿假单胞菌群体感应分子和随后确定的一些生物活性无关的群体感应本身提供了进一步的生化研究的基础上,这个分子,即C12-TA。可以想象,铜绿假单胞菌可能使用C12-TA作为干扰策略,以阻止竞争细菌的侵入,以及作为铁螯合剂和吸收剂的利用,这可能是一个重要的生存策略。最终,从拟议的实验中获得的数据将导致对铜绿假单胞菌发病机制的更深入了解,并可能发现对抗铜绿假单胞菌感染的新治疗靶点。
英文摘要
DESCRIPTION (provided by applicant): Pseudomonas aeruginosa is a common environmental microorganism that has acquired the ability to take advantage of weaknesses in the host immune system to become an opportunistic pathogen in humans. Most prominent is the role of P. aeruginosa in patients suffering from cystic fibrosis as lung defense functions are severely impaired. Over the last 10 years, significant progress has been made in elucidating the molecular mechanisms underlying P. aeruginosa pathogenicity, in which quorum sensing plays a significant role. Two different AHLs, N-(3-oxododecanoyl) homoserine lactone (3-oxo- C12-HSL), synthesized by LasI, and N-butyrylhomoserine lactone (C4-HSL), synthesized by RhlI, have been identified as the main quorum sensing signaling molecules in P. aeruginosa. [PARAGRAPH] Recently, our discovery of a new nonenzymatically-formed product from 3-oxo-C12-HSL, the novel tetramic acid product, 3-(1-hydroxydecylidene)-5-(2-hydroxyethyl)pyrrolidine- 2,4-dione (C12-TA), has generated interest in the microbiological community as evident by the increasing number of citations our PNAS publication has received. Conceivably, this tetramic acid has a plethora of biological functions: P. aeruginosa might use C12-TA as an interference strategy to preclude encroachment by competing bacteria. Additionally, due to the tight and highly specific binding of iron(III) to C12-TA, comparable to known bacterial siderophores, we have hypothesized that this interaction may serve as a previously unrecognized primordial mechanism for iron solubilization and may provide P. aeruginosa with a competitive advantage in complex bacterial communities. Alternatively it might serve as an iron sequestering agent, removing free iron from the environment, thus preventing competing bacteria from obtaining essential iron while also serving as a feedback loop for P. aeruginosa to express genes controlled by the iron starvation Fur/PvdS transcription regulators. Significantly, we have shown that C12-TA affects morphology a in Candida albicans. [PARAGRAPH] Taken in total, we will present a set of hypotheses with highly focused experiments elucidate the molecular features and biochemical functions of N-(3-oxododecanoyl) homoserine lactone-derived C12-TA. PUBLIC HEALTH RELEVANCE: Our recent discovery of a new nonenzymatically-formed product derived from the main Pseudomonas aeruginosa quorum sensing molecule and the subsequent identification of a number of biological activities unrelated to quorum sensing itself provides the basis for further biochemical studies of this molecule, namely C12-TA. It is conceivable that P. aeruginosa might use C12-TA as an interference strategy to preclude encroachment by competing bacteria as well utilization as an iron sequestration and uptake agent, which might be an important survival strategy. Ultimately, the data obtained from the proposed experiments will lead to a deeper understanding of the P. aeruginosa pathogenesis and may uncover new therapeutic targets for combating P. aeruginosa infections.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
An Enzyme-Based Antidote for Acute Nicotine Toxicity
  • 批准号:
    10790758
  • 项目类别:
  • 资助金额:
    $27.15万
  • 财政年份:
    2023
  • 负责人:
    Kim Janda
  • 依托单位:
Discovering modulators of exonucleases PLD3 and PLD4 for immunoregulation
  • 批准号:
    10620110
  • 项目类别:
  • 资助金额:
    $22.19万
  • 财政年份:
    2022
  • 负责人:
    Kim Janda
  • 依托单位:
Discovering modulators of exonucleases PLD3 and PLD4 for immunoregulation
  • 批准号:
    10353980
  • 项目类别:
  • 资助金额:
    $26.63万
  • 财政年份:
    2022
  • 负责人:
    Kim Janda
  • 依托单位:
High-Throughput Screen for the Oncoprotein MYC
  • 批准号:
    10276232
  • 项目类别:
  • 资助金额:
    $43.29万
  • 财政年份:
    2021
  • 负责人:
    Kim Janda
  • 依托单位:
海外基金